Aeolus Pharmaceuticals Receives Usd12.Development of Aeol 10150

Summary


M2 EQUITYBITES-October 11, 2011-Aeolus Pharmaceuticals receives USD12.7m NIH grant to continue the development of AEOL 10150

(C)1994-2011 M2 COMMUNICATIONS http://www.m2.com

See the full content of this document

Extract


Aeolus Pharmaceuticals Receives Usd12.Development of Aeol 10150

Aeolus Pharmaceuticals Inc (OTCQB: AOLS.OB)(Pinksheets: AOLS.OB), a biotechnology company, announced on...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company